Sort
11,323 grants matching “glioblastoma”
Targeting Brain Tumor Stem Cells Through Novel Therapeutic Combinations
$452,315Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · CA
RNA-based Immunotherapy Targeting Antigens Unique to Brain Tumor Stem Cells
$452,151John H Sampson · Duke University · R01 · FY2012 · CA
TRANSCRANIAL FUS THERAPY WITH CLOSED-LOOP US IMAGE GUIDANCE AND CIRCULATING
$452,110Konstantinos-Costas Arvanitis · Georgia Institute Of Technology · R37 · FY2025 · CA
Extracellular Sulfatases As Novel Biomarkers For Early Detection of Cancer
$452,035Hassan Lemjabbar-Alaoui · University Of California, San Francisco · U01 · FY2012 · CA
CAREER: An experimental and numerical investigation of the biophysical processes of pulsed electric field induced irreversible electroporation for Glioblastoma Multiforme
$452,000Rafael V Davalos · Virginia Polytechnic Institute And State University · · FY2011 · ENG
High-throughput Identification and Validation of Drugs to Target Migrating and Treatment-Resistant Glioblastoma Cells
$451,996Young-Tae Kim · University Of Texas Arlington · R15 · FY2025 · CA
The roles of a unique GTP-binding protein/crosslinking enzyme in disease
$451,697Richard A. Cerione · Cornell University · R01 · FY2019 · CA
Plexin-B2 Function in Glioma Invasion
$451,694Roland Horst Friedel · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · NS
Small Molecule Activators of Procaspases as Anti-Cancer Agents
$451,618Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2013 · CA
Deciphering Germline and Somatic Genomic Landscape of Gliomas in Black and Hispanic Minority Groups
$451,357Jason Huse · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Small Molecule Activators of Procaspases as Anti-Cancer Agents
$451,299Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2015 · CA
A microfluidic blood-based test to monitor treatment response in glioblastoma
$451,144Shannon L Stott · Massachusetts General Hospital · R01 · FY2020 · CA
Gene Edited and Engineered Tumor Cell Therapeutics for Cancer
$451,126Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2022 · NS
Plexin-B2 Function in Glioma Invasion
$450,913Roland Horst Friedel · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · NS
Epitranscriptome Associated with Glioblastoma Therapeutic Resistance
$450,875Bakhos A. Tannous · Massachusetts General Hospital · R21 · FY2020 · NS
An innovative integrated computational framework using gene signatures for patient stratification
$450,696Chao Cheng · Baylor College Of Medicine · R01 · FY2025 · CA
Laboratory of Cancer Biology and Genetics Microscopy Core Facility
$450,641Ross Lake · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Mechanisms of targeting cellular self-renewal in glioblastoma
$450,510Hatem Sabaawy · Rbhs -Cancer Institute Of New Jersey · R01 · FY2019 · CA
Radiation-induced vascular reprogramming in glioblastoma
$450,219Harley I Kornblum · University Of California Los Angeles · R01 · FY2024 · NS
iPPSIS: implanted Passive Pressure Sensor Interrogated with (ultra)-Sound
$450,081David Richard Myers · Emory University · R21 · FY2021 · EB
Role of inductive signals released by nasal mesenchyme and brain in controlling terminal nerve development and GnRH-1 neuronal migration
$449,897Paolo E Forni · State University Of New York At Albany · R15 · FY2018 · HD
Project 2: The GABP-TERT axis in immortality of Oligodendroglioma and Glioblastoma
$449,799Joseph F Costello · University Of California, San Francisco · P01 · FY2021 · CA
Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response
$449,513Kathleen Marie Schmainda · Medical College Of Wisconsin · U01 · FY2014 · CA
Synthesis and Study of Cyclotryptamine and Diketopiperazine Alkaloids
$449,502Mohammad Movassaghi · Massachusetts Institute Of Technology · R01 · FY2021 · GM
Toxicity profiling: creating novel paradigms to personalize cancer treatment
$449,326Michael E. Scheurer · University Of Texas Hlth Sci Ctr Houston · R01 · FY2016 · NR